Back to Journals » ClinicoEconomics and Outcomes Research » Volume 7

Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective

Total article views   Abstract views HTML views PDF downloads Totals
11,143 Dovepress* 8,294 1,364+ 1,286 9,658
PubMed Central* 0 1,485 697 1,485
Totals 8,294 2,849 1,983 11,143
*Since 6 May 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
22 1 0 0 9 12

View citations on PubMed Central and Google Scholar